Leumeta ? A New Leukemia/Lymphoma Test
Whilst typical checks search for cancer cells in bone marrow or, in certain cases, peripheral blood, LEUMETA cancer assays track genetic components of leukemia and lymphoma tumors, such as messenger RNA, DNA and protein in blood plasma the liquid portion of the blood. Studies carried out at Quest Diagnostics and The University of Texas MD Anderson Cancer Center and offered at the American Society of Hematology (ASH) meeting in December 2005 showed that info about tumor load and blood cancer markers of leukemia and lymphoma tumors is contained in blood plasma. Sample collection for these LEUMETA assays does not require the distressing extraction of bone marrow cells with a significant-bore needle via the hipbone. Making use of these checks, physicians can get a a lot more regular indication of a sufferers disorder status and make a decision whether or not to alter their remedy, explained Francis Giles, MD, Professor of Medicine and Chief of Developmental Therapeutics in the Department of Leukemia at the MD Anderson Cancer Middle, Houston. In an era of rising focus on targeted therapies, the potential to sequentially obtain so significantly knowledge from blood plasma specimens is a key aid in optimally utilizing the accessible therapies, and in assessing the efficacy of novel agents. To receive this info with out the need for bone marrow tissue is a main advance. Produced by a group of researchers at Quest Diagnostics making use of licensed technological innovation discovered by one of the researchers while formerly at MD Anderson ?
Video Rating: / five
Source: http://www.fbleukemia.info/vidoes/leumeta-a-new-leukemialymphoma-test.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.